IDIBAPS celebrates the kick-off meeting of the Metabolism and Disease Program (MetaDis)
This program aims to decipher the mechanisms underlying metabolic diseases through molecular and systemic studies, analyse interactions between organ1
This program aims to decipher the mechanisms underlying metabolic diseases through molecular and systemic studies, analyse interactions between organ1
A team of experts from the European consortium LIVERSCREEN, led by IDIBAPS and funded by the Horizon 2020 programme (847989) has published the first1
Researchers from Hospital Clínic-IDIBAPS and the CIBER Hepatic and Digestive Diseases (CIBEREHD) have led a European study to evaluate the efficacy o1
Doctors Ginés, Vilaseca and Castro have been recognized with the awards that the Medical Association of Barcelona (COMB) presents each year to profes1
In this perspective article published in Nature Reviews Gastroenterology & Hepatology the authors, experts in the subject, extract the lessons learne1
The project, funded by the European Union and endowed with a budget of 24.8 million euros, aims to identify a large set of biomarkers that allow live1
Researchers at the Hospital Clínic-IDIBAPS led an international study, published in the journal The Lancet, in which they designed an index to determ1
The study, in which Hospital Clínic-IDIBAPS researchers have participated, shows that the perception of this stigma is associated with a deterioratio1
The consortium has begun the second clinical trial to evaluate the efficiency of the combined treatment of simvastatin and the antibiotic rifaximin,1